Veterinary Medicines

Anarthron 100 mg/ml Solution for Injection

Authorised
  • Pentosan polysulfate sodium
Download as PDF

Product identification

Medicine name:
Anarthron 100 mg/ml Solution for Injection
ANARTHRON SOLUTION INJECTABLE 100 MG/ML
Active substance:
  • Pentosan polysulfate sodium
Target species:
  • Dog
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Pentosan polysulfate sodium
    100.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QM01AX90
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • France
Package description:
  • A 10 ml Ph.Eur. Type 1 clear glass vial fitted with a 20 mm rubber stopper Ph.Eur and closed by a plastic flip off seal attached to an aluminium seal.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application - New active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Maperath Herbal Limited
Marketing authorisation date:
Manufacturing sites for batch release:
  • Eurovet Animal Health B.V.
  • Forte Healthcare Limited
Responsible authority:
  • ANSES
Authorisation number:
  • FR/V/3202562 0/2007
Date of authorisation status change:
Reference member state:
  • Netherlands
Procedure number:
  • NL/V/0355/001
Concerned member states:
  • Austria
  • Belgium
  • France
  • Iceland
  • Norway
  • Poland
  • United Kingdom (Northern Ireland)

Documents

Combined File of all Documents

English (DOC)
Published on: 29/03/2022
Download

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 4/04/2022
Download

v10420.pdf

English (PDF)
Published on: 29/03/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."